These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3045335)

  • 1. Cephalotaxine esters: antileukemic advance or therapeutic failure?
    Grem JL; Cheson BD; King SA; Leyland-Jones B; Suffness M
    J Natl Cancer Inst; 1988 Sep; 80(14):1095-103. PubMed ID: 3045335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homoharringtonine as a new antileukemic agent.
    Ohnuma T; Holland JF
    J Clin Oncol; 1985 May; 3(5):604-6. PubMed ID: 3889228
    [No Abstract]   [Full Text] [Related]  

  • 3. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment.
    Chin Med J (Engl); 1976 Jul; 2(4):263-72. PubMed ID: 825360
    [No Abstract]   [Full Text] [Related]  

  • 4. Homoharringtonine: a phase I evaluation.
    Stewart JA; Krakoff IH
    Invest New Drugs; 1985; 3(3):279-86. PubMed ID: 4066221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical investigation of homoharringtonine.
    Legha SS; Keating M; Picket S; Ajani JA; Ewer M; Bodey GP
    Cancer Treat Rep; 1984 Sep; 68(9):1085-91. PubMed ID: 6478448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New natural products in cancer chemotherapy.
    Slichenmyer WJ; Von Hoff DD
    J Clin Pharmacol; 1990 Sep; 30(9):770-88. PubMed ID: 1980498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homoharringtonine--perspectives on an active new natural product.
    O'Dwyer PJ; King SA; Hoth DF; Suffness M; Leyland-Jones B
    J Clin Oncol; 1986 Oct; 4(10):1563-8. PubMed ID: 3531426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the alkaloids of Cephalotaxus. VII. Structures and semi-synthesis of two anticancer cephalotaxine esters].
    Wang DZ; Ma GE; Xu RS
    Yao Xue Xue Bao; 1992; 27(3):173-7. PubMed ID: 1414381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot study.
    Stewart JA; Cassileth PA; Bennett JM; O'Connell MJ
    Am J Clin Oncol; 1988 Dec; 11(6):627-9. PubMed ID: 3189228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.
    Warrell RP; Coonley CJ; Gee TS
    J Clin Oncol; 1985 May; 3(5):617-21. PubMed ID: 3889229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of cephalotaxine esters and correlation of their structures with antitumor activity.
    Mikolajczak KL; Smith CR; weisleder D
    J Med Chem; 1977 Mar; 20(3):328-32. PubMed ID: 845863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the alkaloids of Cephalotaxus. IX. Semi-synthesis of cephalotaxine esters and their anti-leukemic activity].
    Wang DZ; Ma GE; Xu RS
    Yao Xue Xue Bao; 1992; 27(3):178-84. PubMed ID: 1414382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
    Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
    Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
    [No Abstract]   [Full Text] [Related]  

  • 14. Homoharringtonine: history, current research, and future direction.
    Kantarjian HM; Talpaz M; Santini V; Murgo A; Cheson B; O'Brien SM
    Cancer; 2001 Sep; 92(6):1591-605. PubMed ID: 11745238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia.
    Yang Y; Yu Q; Hu L; Dai B; Qi R; Chang Y; Zhang Q; Zhang Z; Li Y; Zhang X
    Eur J Med Chem; 2022 Dec; 244():114731. PubMed ID: 36242991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrathecal injection of harringtonine and homoharringtonine in treating central nervous system leukemia--clinical analysis of 26 cases (author's transl)].
    Hou CH; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):530-2. PubMed ID: 6804061
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined harringtonine or homoharringtonine chemotherapy for acute nonlymphocytic leukemia in 25 children.
    Li YH; Guo SF; Zhou FY; Xu SZ; Zhang HL
    Chin Med J (Engl); 1983 Apr; 96(4):303-5. PubMed ID: 6413148
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trial of homoharringtonine in children with refractory leukemia.
    Tan CT; Luks E; Bacha DM; Steinherz P; Steinherz L; Mondora A
    Cancer Treat Rep; 1987 Dec; 71(12):1245-8. PubMed ID: 3480043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of homoharringtonine.
    Smith CR; Powell RG; Suffness M
    J Clin Oncol; 1986 Aug; 4(8):1283. PubMed ID: 3525773
    [No Abstract]   [Full Text] [Related]  

  • 20. Omacetaxine mepesuccinate for the treatment of leukemia.
    Kim TD; Frick M; le Coutre P
    Expert Opin Pharmacother; 2011 Oct; 12(15):2381-92. PubMed ID: 21916787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.